Prognostic gene expression signature for high-grade serous ovarian cancer
2020 · Annals of Oncology · 167 citations
https://doi.org/10.1016/j.annonc.2020.05.019
I
Ian Hammond
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
137
Papers
3.9K
Citations
33
h-index
71
i10-index
Ian Hammond is an academic researcher from Royal Women's Hospital. The author has contributed to research in topics: Uterine Myomas and Treatments & Ovarian cancer diagnosis and treatment & Endometrial and Cervical Cancer Treatments. The author has an h-index of 33, co-authored 117 publications.
ORCID: 0000-0002-5225-3144Papers by this author
worksTiming of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer
2024 · Nature Communications · 14 citations
https://doi.org/10.1038/s41467-024-50137-y
Bone Mineral Densitometry Reporting and the CAR Technical Standards: Tips for the Radiologist
2020 · Canadian Association of Radiologists Journal · 6 citations
https://doi.org/10.1177/0846537119899270
Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer
2023 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-023-48153-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat